Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

PAD type III enzyme is specific to rat skin and hair follicles.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

PADs are crucial for healthy skin and hair, and their imbalance can cause skin and hair disorders.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Phospholipids help plant proteins move by regulating receptor interactions.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

RADA-PDGF2 hydrogel speeds up wound healing and is safe for use.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Blocking Prostaglandin D₂ may help treat hair loss.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Palmitoyl-GDPH speeds up wound healing and improves tissue regeneration without toxicity.

Deltsid 7.5 is the most effective treatment for bovine psoroptosis.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

The diphosphonate was the most effective at preventing calcification in rats.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

A new compound effectively inhibits human 5α-reductase 1.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.